Template:Triptans: Difference between revisions
From WikiMD's Wellness Encyclopedia
en>Arcadian moved Template:Triptans to Template:Antimigraine preparations: more general |
m 1 revision imported |
||
| Line 1: | Line 1: | ||
# | {{Navbox | ||
| name = Antimigraine preparations | |||
| title = [[Antimigraine drug|Antimigraine]] preparations ([[ATC code N02#N02C|N02C]]) | |||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} | |||
| bodyclass = hlist | |||
| group1 = [[Management of chronic headaches#Analgesic and abortive medications|Analgesic/abortive]] | |||
| list1 = {{Navbox|child | |||
| group1 = [[Serotonergic]]s | |||
| list1 = {{Navbox|child | |||
| group1 = [[Ergoline]]s | |||
| list1 = | |||
* [[Dihydroergotamine]] | |||
* [[Ergotamine]] | |||
* [[Methysergide]] | |||
* [[Lisuride]] | |||
| group2 = [[Serotonin receptor agonist|5-HT<sub>1</sub> agonists]] | |||
| list2 = {{Navbox|child | |||
| group1 = [[Triptan]]s | |||
| list1 = | |||
* [[Almotriptan]] | |||
* [[Avitriptan]] | |||
* [[Eletriptan]] | |||
* [[Frovatriptan]] | |||
* [[Naratriptan]] | |||
* [[Rizatriptan]] | |||
* [[Sumatriptan]] | |||
* [[Zolmitriptan]] | |||
| group2 = [[Ditan]]s | |||
| list2 = | |||
* [[Alniditan]]<sup>§</sup> | |||
* [[Lasmiditan]] | |||
}} | |||
| group3 = Others | |||
| list3 = | |||
* [[Dimetotiazine]] | |||
* [[Dotarizine]] | |||
* [[Iprazochrome]] | |||
* [[Oxetorone]] | |||
* [[Pizotifen]] | |||
}} | |||
| group2 = [[Calcitonin gene-related peptide receptor antagonist|CGRP-R antagonists]] | |||
| list2 = | |||
* [[Rimegepant]] | |||
* [[Ubrogepant]] | |||
| group3 = Others | |||
| list3 = | |||
* [[Paracetamol]]<sup>#</sup> | |||
* [[Amidrine]] | |||
}} | |||
| group2 = [[Prevention of migraines|Prophylactic]] | |||
| list2 = {{Navbox|child | |||
| group1 = [[Calcium channel blocker]]s | |||
| list1 = | |||
* [[Dotarizine]] | |||
* [[Lomerizine]] | |||
* [[Verapamil]] | |||
* [[Flunarizine]] | |||
| group2 = [[Progestogen]]s | |||
| list2 = | |||
* [[Flumedroxone acetate]] | |||
| group3 = [[Sympatholytic]]s | |||
| list3 = | |||
* [[Beta blocker]]s | |||
** [[Propranolol]]<sup>#</sup> | |||
** [[Timolol]] | |||
* [[Clonidine]] | |||
| group4 = [[Tricyclic antidepressant]]s | |||
| list4 = | |||
* [[Amitriptyline]] | |||
* [[Nortriptyline]] | |||
* [[Imipramine]] | |||
| group5 = [[Anticonvulsant]]s | |||
| list5 = | |||
* [[Carbamazepine]] | |||
* [[Oxcarbazepine]] | |||
* [[Topiramate]] | |||
* [[Valproate]] | |||
| group6 = Anti-[[Calcitonin gene-related peptide|CGRP]]/[[CALCRL|CGRP-R]] [[Monoclonal antibody|mAb]]s | |||
| list6 = | |||
* [[Eptinezumab]] | |||
* [[Erenumab]] | |||
* [[Fremanezumab]] | |||
* [[Galcanezumab]] | |||
}} | |||
| group3 = | |||
| list3 = | |||
{{PharmNavFootnote}} | |||
}}<noinclude> | |||
{{collapsible option}} | |||
[[Category:Drug templates by ATC]] | |||
</noinclude> | |||
Revision as of 05:54, 29 April 2024
| Antimigraine preparations (N02C) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
